Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

5.15USD
26 Apr 2018
Change (% chg)

$0.05 (+0.98%)
Prev Close
$5.10
Open
$5.10
Day's High
$5.15
Day's Low
$5.10
Volume
308
Avg. Vol
13,324
52-wk High
$15.19
52-wk Low
$4.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.937
Mar '17 0.00 -0.894
FY 2016 Dec '16 0.00 -1.505
Sep '16 0.00 -1.981
Jun '16 0.00 -1.470
Mar '16 0.00 -1.292
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.50 -0.50 -0.50 --
Quarter Ending Sep-18 1 -0.52 -0.52 -0.52 --
Year Ending Dec-18 2 -2.16 -2.05 -2.28 -33.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 173.69 32.21
P/E High - Last 5 Yrs. -- 277.43 45.93
P/E Low - Last 5 Yrs. -- 94.83 24.67
Beta 1.63 0.74 0.79
Price to Sales (TTM) -- 143.31 7.12
Price to Book (MRQ) 0.49 18.56 4.90
Price to Tangible Book (MRQ) 1.37 23.03 6.48
Price to Cash Flow (TTM) -- 113.95 24.70
% Owned Institutions 14.25 11.14 2.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.57
Dividend Yield - 5 Year Avg -- 0.20 0.77
Dividend 5 Year Growth Rate -- 1.99 4.07
Payout Ratio(TTM) -- 9.34 20.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 102.04 9.38
Sales (TTM) vs TTM 1 Yr. Ago -- 78.42 11.18
Sales - 5 Yr. Growth Rate -- 33.22 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.23 -68.08 24.18
EPS (TTM) vs TTM 1 Yr. Ago 4.79 -- --
EPS - 5 Yr. Growth Rate -- 45.94 10.39
Capital Spending - 5 Yr. Growth Rate 25.26 44.70 10.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.53
Current Ratio (MRQ) 25.42 5.98 3.59
LT Debt to Equity (MRQ) 0.00 23.74 11.47
Total Debt to Equity (MRQ) 0.00 26.24 14.16
Interest Coverage (TTM) -- -176.11 30.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 34.08 54.23
Gross Margin - 5 Yr. Avg. -- 55.28 52.19
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -148.90 15.91
Operating Margin (TTM) -- -586.11 3.78
Operating Margin - 5 Yr. Avg. -- -161.04 11.22
Pre-Tax Margin (TTM) -- -558.30 4.45
Pre-Tax Margin - 5 Yr. Avg. -- -168.34 11.53
Net Profit Margin (TTM) -- -546.50 1.07
Net Profit Margin - 5 Yr. Avg. -- -168.59 7.86
Effective Tax Rate (TTM) -- -0.47 31.76
Effective Tax Rate - 5 Yr. Avg. -- 18.03 24.25

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,213,484 790,924,504
Net Income/Employee (TTM) -1,102,105 651,754 92,823,068
Receivable Turnover (TTM) -- 6.13 5.51
Inventory Turnover (TTM) -- 2.42 3.47
Asset Turnover (TTM) 0.00 0.40 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.87 -0.73 10.41
Return on Assets - 5 Yr. Avg. -52.08 0.50 11.41
Return on Investment (TTM) -41.68 -0.70 13.05
Return on Investment - 5 Yr. Avg. -55.12 4.02 14.78
Return on Equity (TTM) -41.68 -2.69 14.90
Return on Equity - 5 Yr. Avg. -55.12 -0.12 16.12
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 0.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Arcturus Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.63%
# of Holders: 25
Total Shares Held: 1,564,275
3 Mo. Net Change: 50,799
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 1
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.